Zhongnan Medical Journal Press

Home Results

A total of 4 result was found. Results that relate to Lung adenocarcinoma

Treatment of a patient with EGFR L747S and L858R double-mutated lung adenocarinoma

Published on Journal of Mathematical Medicine 2023,36(3):230-235.
5635 times 1546 times

Teng-Fei WANG Wen OUYANG Jun-Hong ZHANG Gong ZHANG Cong-Hua XIE

EGFR L747S mutation Lung adenocarcinoma Osimertinib Pem-brolizumab
Details
Comparative study of two antiangiogenic agents combined with pemetrexed and carboplatin in patients with EGFR-TKI-acquired resistant advanced lung adenocarcinoma

Published on Frontiers in Pharmaceutical Sciences 2024,27(7):1162-1169.
8176 times 1514 times

XIONG Jufang GUO Xingyu ZHOU Meiying

Anrotinib Bevacizumab EGFR-TKI resistance Advanced lung adenocarcinoma Acquired drug-resistance
Details
Construction of a prognostic nomogram for lung adenocarcinoma patients based on immune scores

Published on Journal of Mathematical Medicine 2024,37(9):649-656.
9796 times 1461 times

YAO Wei WANG Pingfei

Lung adenocarcinoma Immune scores Nomogram Prognosis
Details
Pharmaceutical practice of bevacizumab-induced refractory hypertension and proteinuria in a patient with advanced lung adenocarcinoma

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1335-1339.
557 times 104 times

YAN Jiaju YUAN Yongyong LIU Meng

Bevacizumab Lung adenocarcinoma Resistant hypertension Proteinuria Phamaceutical care
Details